Tandem Diabetes Care, Inc. 2025-2026 Proxy Voting Records

1. To approve, on a non-binding, advisory basis, the compensation of our named executive officers.

Combines 11 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Proposal 2: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement”): 53,460,747 for, 1,481,027 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 78% for, 2% against (80% of the company cast a for/against vote).

The 310 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

Showing the 25 largest of 310 asset managers. See all 310 in the interactive database.

2. To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rebecca Robertson

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Rebecca Robertson”): 54,160,282 for, 799,310 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 79% for, 1% against (80% of the company cast a for/against vote).

The 73 asset managers below cast 99.7% of the shares they voted on this item FOR (25,035,357 for, 69,427 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

3. To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Sandra Beaver

Combines 4 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Sandra Beaver”): 54,607,191 for, 348,050 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 80% for, 0.6% against (80% of the company cast a for/against vote).

The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (25,075,683 for, 29,100 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

4. To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Myoungil Cha

Combines 4 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Myoungil Cha”): 54,456,358 for, 502,290 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 79% for, 0.8% against (80% of the company cast a for/against vote).

The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (25,070,044 for, 34,740 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

5. To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Peyton Howell

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Peyton Howell”): 54,179,597 for, 773,220 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 79% for, 1% against (80% of the company cast a for/against vote).

The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (25,070,039 for, 34,745 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

6. To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Joao Malagueira

Combines 4 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Joao Malagueira”): 54,454,159 for, 499,747 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 79% for, 0.8% against (80% of the company cast a for/against vote).

The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (25,070,044 for, 34,740 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

7. To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Kathleen McGroddy-Goetz

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Kathleen McGroddy-Goetz”): 54,312,399 for, 641,726 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 79% for, 1.0% against (80% of the company cast a for/against vote).

The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (25,064,456 for, 40,328 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

8. To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: John Sheridan

Combines 4 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: John Sheridan”): 54,432,569 for, 536,164 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 79% for, 0.8% against (80% of the company cast a for/against vote).

The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (25,070,043 for, 34,740 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

9. To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rajwant Sodhi

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Rajwant Sodhi”): 54,328,131 for, 621,295 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 79% for, 1.0% against (80% of the company cast a for/against vote).

The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (25,064,456 for, 40,328 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

10. To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey

Combines 4 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Christopher Twomey”): 47,921,655 for, 7,034,208 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 70% for, 10% against (80% of the company cast a for/against vote).

The 73 asset managers below cast 89% of the shares they voted on this item FOR (22,328,478 for, 2,776,306 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

11. To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law ("DGCL").

Combines 6 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Proposal 4: To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the DGCL”): 57,818,029 for, 126,025 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 84% for, 0.2% against (85% of the company cast a for/against vote).

The 73 asset managers below cast 100% of the shares they voted on this item FOR (25,104,784 for, 0 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

12. To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL.

Combines 3 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Proposal 5: To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as ”): 45,926,405 for, 9,043,831 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 67% for, 13% against (80% of the company cast a for/against vote).

The 73 asset managers below cast 85% of the shares they voted on this item FOR (21,458,971 for, 3,645,814 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

13. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Proposal 6: To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 57,493,084 for, 454,735 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 84% for, 0.7% against (85% of the company cast a for/against vote).

The 73 asset managers below cast 99.8% of the shares they voted on this item FOR (25,076,131 for, 28,654 against).

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

14. To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares authorized for issuance under the plan.

98% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Proposal 3: To approve the Amended Plan to, among other things, increase the number of shares authorized for issuance under the plan”): 53,846,696 for, 1,108,529 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 79% for, 2% against (80% of the company cast a for/against vote).

The 72 asset managers below cast 99.7% of the shares they voted on this item FOR (26,151,939 for, 68,983 against).

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

15. Amend Omnibus Stock Plan

98% Majority: yes · of votes cast

Tandem Diabetes Care, Inc.’s own tally for this item (“Proposal 3: To approve the Amended Plan to, among other things, increase the number of shares authorized for issuance under the plan”): 53,846,696 for, 1,108,529 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 68,529,089 outstanding shares: 79% for, 2% against (80% of the company cast a for/against vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (78,599 for, 0 against).